All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
IHE real return snapshot: After CPI-U inflation, IHE returned +32.34% over the past year and +0.45% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +324.00% in real purchasing-power return, or +7.48%/yr, and is currently ā6.44% below its real total-return high on Feb. 27, 2026.
| Fri 2006-05-05? to Mon 2026-05-18 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| IHE × |
+0.45%
2026-05-18 |
+32.34%
2026-05-18 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05? to Mon 2026-05-18 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+324.00%
+7.48%/yr |
+8.00%/yr
(R2=0.821) |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05? to Mon 2026-05-18 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$42,399.85
2026-05-18 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Year | IHE |
|---|---|
| 2026 (YTD) | +0.45% |
| 2025 | +28.26% |
| 2024 | +5.10% |
| 2023 | ā2.21% |
| 2022 | ā10.65% |
| 2021 | +5.63% |
| 2020 | +12.13% |
| 2019 | +12.89% |
| 2018 | ā9.49% |
| 2017 | +8.35% |
| 2016 | ā13.54% |
| 2015 | +8.02% |
| 2014 | +28.93% |
| 2013 | +38.51% |
| 2012 | +11.45% |
| 2011 | +17.46% |
| 2010 | +11.05% |
| 2009 | +26.66% |
| 2008 | ā15.00% |
| 2007 | ā1.66% |
| 2006 | +6.44% |
| Fri 2006-05-05? to Mon 2026-05-18 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| IHE × |
ā6.44%
from 2026-02-27 peak |
ā39.57%
2009-03-05 from 2007-05-22 peak |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Period ending Mon 2026-05-18 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| IHE × | +32.34% |
+29.05% +13.59%/yr |
+43.31% +12.74%/yr |
+24.55% +4.49%/yr |
+56.26% +4.57%/yr |
|
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||